Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search

You are here Our Research > Spinout Companies

Spinout Companies







Solvotrin Therapeutics
Founded by Prof. John Gilmer
Solvotrin’s lead product ST0702 has major benefits to offer as an anti metastatic agent in colorectal cancer due to its aspirin anti-platelet effects, with additional super-aspirin de-cloaking effects of its lipophilic metabolite.





Back to top